vimarsana.com
Home
Live Updates
Early RUBY-3 Data Shows Promise for Povetacicept in Glomerulonephritis : vimarsana.com
Early RUBY-3 Data Shows Promise for Povetacicept in Glomerulonephritis
Preliminary data from the open-label RUBY-3 trial were presented at the American Society of Nephrology Kidney Week 2023.
Related Keywords
United States ,
Emory University School Of Medicine ,
Georgia ,
American ,
James Tumlin ,
Jonathan Barratt ,
American Society Of Nephrology Kidney Week ,
University Of Leicester ,
Alpine Immune Sciences ,
Nephronet Clinical Trials Consortium ,
Georgia Nephrology ,
American Society ,
Nephrology Kidney Week ,
Emory University School ,
Nephronet Clinical Trials ,
Kidney Week ,
Immune Sciences ,
Mayer Professor ,
Renal Medicine ,
Enhanced Dual ,
Autoantibody Associated Glomerulonephritis ,
Paper Presented ,
Autoimmune Glomerulonephritis ,
Late Breaking Poster Session ,
vimarsana.com © 2020. All Rights Reserved.